Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated

Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated

US Patent 7601697 · Granted Oct 13, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Breast and ovarian cancer vaccines2024
Methods and materials for expanding antigen-specific T cells in culture2023
Methods and vaccines for inducing immune responses to multiple different MHC mol2022
Breast and ovarian cancer vaccines2021
Breast and ovarian cancer vaccines2021
Cancer vaccine compositions and methods of use thereof2020
Methods and materials for expanding antigen-specific T cells in culture2020
HLA-DR binding peptides and their uses2020
Breast and ovarian cancer vaccines2019
Molecules and methods for treatment and detection of cancer2015
HER-2/neu fusion proteins2013
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for 2013